Loading...
Pharmacological treatment of obsessive-compulsive disorder
Obsessive-compulsive disorder (OCD) affects up to 2.5% of the population of the course of a lifetime and produces substantial morbidity. Approximately 70% of patients can experience significant symptomatic relief with appropriate pharmacotherapy. The selective serotonin reuptake inhibitors (SSRIs) a...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4143776/ https://ncbi.nlm.nih.gov/pubmed/25150568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.psc.2014.05.006 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|